IFNB1 and neoplasm: This modification impedes the M protein ability to block the IFN-β mRNA transport from the nucleus to the cytoplasm and thus affects the antagonistic activity of IFN, limiting the virus replication to tumor cells incapable of producing IFN, allowing infected normal cells to produce a normal IFN response and therefore limiting the virus spread.